Subaru is Cheap!FUJHY is cheap by several metrics and warrants a multiple expansion!
- TTM GAAP PE is 71% below sector median
- FWD GAAP PE is 70% below sector median and 53% below its 5 year average.
-EV/EBITDA TTM and FWD are 92 and 94% below sector media; both are about 72% its 5 year avg
-P/S, P/FCF, P/B all are substantially below sector median and its 5 year avg
-DCF based on FCF and 7% discount rate implies a margin of safety at 89.1%
-Shiller PE is 8.34, during the past 10 years, Subaru's highest Shiller PE Ratio was 31.54. The lowest was 6.70. And the median was 10.74. Subaru's shiller PE is ranked better than 84% of 739 companies in the vehicle and parts industry.
-Technically, FUJHY is sitting near the bottom of a long term uptrend and appears to be finding a bottom within a flat channel and starting to trend up.
Subaru has been able to recover to its 2017-2018 profitability and net income range while projecting FWD growth. Given these considerations Subaru appears to be very cheap on several time frames and metrics.
Undervalued
$NSE:ELECTCAST READY TO CAST NEW HIGHNSE:ELECTCAST is getting casted to cast new high's. As you all can see and observe the charts, The charts have formed double bottom along with ascending triangle pattern.
While writing this price has already broken out through ascending triangle and checking for volumes they have been good since last three months. Since this stock has already given 2x from march to till date it is risky buy here for me.
But still seeing the stocks technical and fundamentals this stock is so good to be true. We could see institutional buying and the chart is also showing bullishness with strong technical volume data.
Note:- Set Stop loss according to your apatite.
As indicated the new target for this stock with CMP:- 210 would be
1. Short term Targets
225
230
2. Mid Term Targets
240
255
3. Long Term Target
269
280
299
If all goes well soon Electro steel cast will cast new highs.
If you like my analysis do give a follow and boost to bring you more analysis.
Disclaimer
The above analysis posted is only for my reference. And it is not investment advice. These post are for educational purpose only. Please DYOR before investing you hard earned money. I am not responsible either for you profit or losses you make out of my analysis.
Mock Up Price Action for CSPRUSDT | Near/Mid Term (3D)Mock Up Price Action for KUCOIN:CSPRUSDT | Near/Mid Term (3D)
This is it. Bottoming structure, level out, then begins our bullish cycle and movement upward. DCA buying in heavily here. Every, single, dip. Looking forward to what's to come.
charts.cointrader.pro
Buy ITC cmp 425.50, target minimum 480, SL-399Fundamentally and technically sound, ITC is a perfect buy looking at overall market conditions which is currently on high valuations. At current price, ITC provides a value comfort and technically this stock has done a price and time correction at the same time. Currently we see that chart is forming Inverted Head & Shoulders pattern on a daily time frame which is extremely bullish pattern and indicates the reversal of downfall and bottom formation. Aggressively buy this stock at 425-430 levels and wait patiently for a minimum target of 480, stop loss at 399.
VTYX- a risky biotechnology penny stock LONGVTRX is on a 120 minute chart, currently trading at 90% off its ATH and 50% above its absolute
long term support level. Price tried to cross above the long term mean VWAP 3 months ago
but was rejected. I anticipate that in time it will try to so so again. From 3.3 to a target of 9
would be a move in the neighborhood of 300%. I will take a small position long trade here.
This will be highly volatile. I will place a 25% stop loss to give VTRX room to roam for a couple
of earnings periods. Once the price rises 25% I will convert to a trailing stop loss of 25% and
make the then risk free trade low maintenance.
NIO ? Are traders ready to love it again LONGNIO on the daily is 95% below its ATH Winter of 2021 and 50% lower YTD. In China NIO is
competing well with XPEV, LI , BYD and TSLA while it makes further penetrative into the
EU market. Its unique concept in action is battery leasing and battery swapping making
charging time no longer relevant. Apparently, the battery swapping time from a depleted
battery to one carrying a charge is 15-20 minutes. Being a bottom-seeking bargain hunter quite
often, I will take a long trade here with a planned duration of two earnings periods.
GALA $0.025 | Reset for next Bull Run and Circusjust now
i missed out in this one maybe get a chance for accommodation at depressed levels
great team yet to find that one global game to spur interest and renew interest of speculators and big funds
cost of BANKER is $0.008 cents
buffer to keep those investors should be at $0.015 zone
www.sandbox.game
Can SBUX rise from beating beaten down 15% YTD ?SBUX of late has been in a descending channel and has sloped down heavily in April.
It is now in deep undervalued and overbought territory at the bottom of the channel and
above the 3rd lower VWAP band line. The RSI lines ( both faster and slower) are bearish as
well. My trade plan is to watch Starbucks for a reversal which may be signaled by
bullish divergence on the RSI. SBUX has fallen through a volume void under the high volume
area. Once it reverses it could rise fairly quickly to 90 and then slower to 94. These will be
the targets.
TAP ( Coors Molson Miller ) Ready for Bullish Continuation?On the daily chart, TAP was on a good trend up heading into earnings which were favorable.
It is consolidated since just after earnings in a " high tight bull flag pattern" Volume has been
healthy with many buyers and seller trading shares in a tight range channel. The stochastic
RSI is now at about 20% indicating TAP is in the oversold / undervalued area. The optimized
artificial intelligence moving average indicator shows parallel rises in both the short and long
MAs ( neither divergence nor convergence just consistent ). This is a minor healthy pullback
and a good entry point.
Fundamentally, the summer beer- drinking season will soon arrive. TAP may be benefitting
from the BUD backlash over the Bud Lite endorsement controversy.
My call options have been appreciated 50% in the past 2 1/2 weeks ( 4% per trading day ).
I will roll them into the call options expiring 9/15/23. I consider TAP to be a steady
consistent gainer and likely more or less recession-proof.
FSM a silver junior miner poised to profit on silver's momentum FSM is on a 30-minute chart. The trade idea is that FMS suffers in drops in spot sliver but
thrives when spot silver rises as its fixed expenses in mining allow for increases in margin
in a curvilinear fashion when spot silver rises. This is more so than a senior miner such as FCX
that moves slower when metal prices rise or fall. I see the quick geopolitical dip in spot silver
as an opportunity to pick up junior miners ( including GDXJ the ETF) at a discounted price to
be held for spot silver recovery and then averaged out for realization of profits.
Chainlink (LINK): Oversold and Undervalued. Surge to $37+Finally, after a long wait, we got filled on Chainlink, and we entered at $12.93. This is our entry point. The entry is holding up quite well and solid so far. We still see strength in Chainlink and we do not believe that our large stop-loss will be triggered. Also, for the first time since May 2022, the RSI has fallen into the oversold area, which is another sign of how strongly Chainlink has been sold off. We are holding on to this and still expect an increase to at least $37.45, probably even to $47.45.
EL jumps on analyst upgrade LONGEL like ULTA was beaten down in covid times. It jumped in 2021 and fell in 2022 and 2023.
2024 might be the year they thrive again. On the weekly chart, EL is back to the support of
its levels of 2018. With an analyst upgrade coming from Bank of America it is now getting a
bit of attention. Trend strength and relative strength were down. I see this as a good entry
for a new long position in EL while also looking at ULTA. Targets are the fib zone and a
correction / consolidation area on the downtrend so 200 and 250. Now is the time to invest
in female beauty.....
RH appears ready to rise from its base LONGRestoration Hardware on the weekly chart rose from COVID and then retraced for almost
two years. It appears now ready to experience some investor and trader interest once again.
It is rising from the POC line of its long term volume profile. The trend strength indicator just
inflected and curled upward. I like to catch trends early to get as much of a move as
possible and before the chasing begins. This is a possible megacap short squeeze set up.
Targets are 380 and 480 as horizontal levels of importance.
SoFi's Surge: Unveiling 2023 and What Lies Ahead in 2024Technical Analysis Overview
Current Price : $10.34, a 3.77% increase.
Weekly Trend : Showing a positive trend with a 5.35% increase over the last five days.
1-Month Trend : A significant increase of 51.96%, indicating strong bullish sentiment.
6-Month and Yearly Trends : A 17.04% increase over the last six months and a 124.51% increase year to date, highlighting a robust bullish trend.
Advanced Technical Indicators
Relative Strength Index (RSI) : 70.41 - Indicating that SOFI is nearing overbought territory, which could lead to a potential reversal or consolidation in the short term.
Moving Average Convergence Divergence (MACD) : 0.63 - Suggesting bullish momentum, indicating a strong buying trend.
Other Indicators : STOCH (83.28), STOCHRSI (84.02), ADX (37.09), Williams %R (-8.57), CCI (104.63), ATR (0.46), Ultimate Oscillator (54.76), and ROC (24.66) all contribute to a picture of current bullish momentum but with potential for short-term volatility or pullback.
Market Sentiment and External Factors
Market Capitalization : $9.904B USD.
Trading Volume Analysis : A high trading volume of 35,199,288, suggesting active market participation and interest in the stock.
Recent News Coverage Impacting SOFI
Bullish Outlook for 2024 : Analysts predict SOFI stock could continue its rally in the new year, benefiting from expected interest-rate cuts. A notable analyst has set a high price target of $14 for SOFI stock, implying significant upside potential ( InvestorPlace ).
Focus on Non-Lending Businesses : Analysts appreciate SoFi's shift towards non-lending businesses, improving earnings quality despite a higher-for-longer interest-rate policy.
Central Bank Policy Changes : Potential interest rate cuts in 2024 could benefit SoFi's lending business, as lower rates tend to spur borrowing and lending activity.
Conclusion
SOFI's stock shows strong bullish signs in the medium to long term, but the current overbought condition warrants caution for short-term traders.
The recent news and analyst predictions provide a positive outlook for 2024, making SOFI an interesting stock for both traders and long-term investors.
NVAX- a medical penny stock Buy Weakness LONGNVAX on a 120 minute chart demonstrates a trend down in the past month after a period of
consolidation producing the POC line on the volume profile. The MACD shows some bullish
divergence. The volume profile has high volume nodes at 4.0 and 5.0 separated by a relative
volume void. NVAX fell quickly through that void. It can just as easily rise through it. See the
linked article on NVA from TipRanks. Options volume and pricing analysis is that bets are looking
at5.0 diligently. Fundamentally, NVAX has been range limited by its focus on COVID but it does
have other projects in its pipeline admittedly on various timelines with varying probabilities
of capitalizing on them depending on clinical trials FDA approvals and so on. On the imbedded
relative strength table as compared with SPY and peers in the pharmaceutical, biotechnology,
medical device and healthcare spaces NVAX compares favorably with MRNA its closest peer
but is weak compared with most of the others I have selected especially with LLY, which is
high-flying from its anti-obesity drug breakout. Device companies Stryker and Intuitive Surgical
are quite strong as well. United Healthcare is dominant in the insurance subsector and strong
overall.
One often effective strategy is to buy when an instrument is oversold and undervalued at a
discount. I will buy NVAX here no matter that I have insider connections with one of those
medical device companies and a few not on the list. Sentiment only goes
so far. I found the article compelling and so Novavax long I go. On a trading site left unsaid
my screenname is "Bottom Feeding Grinder". I have an appetite for NVAX found at the bottom
right now. This is a reversal/reversion to the mean long trade. It is not without risk. As a
penny stock with high volumes, low cost of entry and perhaps low floats, volatility is
underscored and exaggerated if a volume inflow gets underway That said, a short squeeze
is within the spectrum of possibilities. Enough said for now.
GE Buy the Pullback ( Flip the switch) now LONG I previously published the idea of shorting GE. It has now pulled back more than 4%
on the retreacement. The short idea paid well using put options to profit from the
pump of earnings expectations. Earnings were great but the run up was too much for
traders. GE has now retreated and is ready for a long entry. Price is now in the
undervalued range of both the short and intermediate term VWAP bands.
The target is $99.99which is basically the price immediately before the earnings report.
Confirmation is tbe zero lag MACD where the K/D lines crossed under the histogram and are heading
together to cross over the zero line while the histogram flipped from negative to positive.
Call options in the money expiring 5/5 are considered.
ROKU falls after an earnings beat dissapointmentROKU on the 30 minute chart had a sell-off after earnings which were okay not great. Traders
reacted. The question is whether it was an overreaction. I think it was. I am looking for a slow
recovery over a week or more to at least the standard retracement level which I will call 98 as
drawn by the tool. further upside targets are 101 and 104 based on VWAP bandlines.
Buying on the discount is sometimes an excellent tool to reduce risk and use the reversion to
the mean to best advantage and seize an overreaction in the market.
Morgan Stanley rated A the Ping An Insurance for secong year
Revenue: $156.2 billion
Net Income: $14.7 billion
Market Cap: $114.8 billion
1-Year Trailing Total Return: ~7.5%
Exchange: OTC Markets
According to Investopedia, it is the 3rd biggest Chinese company and in the top 5 insurance companies in the world
Ping An Insurance provides insurance, financial services, and banking. It is one of the top 50 companies on the Shanghai Stock Exchange.
Founded in 1988, it was China's first joint-stock insurance company.
Its subsidiaries include Ping An Life, Ping An Property & Casualty, Ping An Annuity, and Ping An Health.
Hong Kong and Shanghai, Nov. 29, 2023 /PRNewswire/ -- Ping An Insurance (Group) Company of China, a powerhouse in the insurance sector, proudly declares its stellar achievement in the latest Environmental, Social, and Governance (ESG) Ratings by Morgan Stanley Capital Investment (MSCI). Securing an A rating for the second consecutive year, Ping An reaffirms its commitment to sustainable practices. Notably, the Group maintains its top-tier position in the multi-line insurance & brokerage industry in the Asia-Pacific (APAC) region. This accolade underscores Ping An's unwavering dedication to excellence and responsible corporate citizenship. Investors take note of Ping An's remarkable ESG track record as it continues to lead the way in the industry.
Ping An takes proactive steps in addressing climate change challenges, utilizing its integrated finance capabilities to advance green finance initiatives and support China's ambitious targets of achieving "carbon peak and neutrality in 2030 and 2060 respectively." In responsible investment, Ping An implements the active ownership principle, integrating Environmental, Social, and Governance (ESG) factors into research, analysis, and investment decisions. The company actively oversees and participates in ESG management for portfolio companies, ensuring their healthy development. By June 2023, Ping An's green investments in insurance assets reached an impressive RMB140.929 billion.
The current entry-level is looking promising being close to the all-time lows with much higher upside potential than the downward one.
The Bullish Case for TESLAOne of the biggest misconception on Tesla is that it is just an Electric Vehicle Company but that is not the case. Tesla is also a Robotics, AI and energy company. If you look at it from that lens, TESLA is undervalued and has a great future!!
TESLA recently bounced off the $212 Support level and believe this is the start of a bullish trend. Targeting the $300 Price point and we may even see $300 by the end of 2024.
For context Elon recently tweeted this on TESLA
"I am uncomfortable growing Tesla to be a leader in AI & robotics without having ~25% voting control. Enough to be influential, but not so much that I can't be overturned.
Unless that is the case, I would prefer to build products outside of Tesla. You don't seem to understand that Tesla is not one startup, but a dozen. Simply look at the delta between what Tesla does and GM. As far as stock ownership itself being enough motivation, fidelity, and other similar stakes to me, why don't they show up for work?"
In this tweet, Elon Musk expresses his desire for greater control over Tesla's direction as the company expands into AI and robotics. He believes that his current 13% stake in the company is not enough to make significant decisions in these areas.
Tesla has a great future and as long as Elon is the captain, this ship will continue to go to mars and beyond. cheers
Is Sanofi Undervalue by 22% ?I wanted to share an analysis I've conducted on Sanofi over the past five years using both comparable methods and a 2-Stage DCF approach. According to my findings, the market value appears to be at least 22% undervalued in comparison with its fair value. Moreover, considering the post-COVID effects on pharmaceutical companies, I believe Sanofi presents a compelling opportunity to purchase its stock with potentially lower risk.
I would be glad to share my detailed analysis for any one interested in more in debt explorations
Disclaimer:
This information is based on my personal analysis and is not to be considered financial advice. I am expressing my own views and opinions on the current market conditions and Sanofi's stock. Always conduct your own research and consider seeking advice from a qualified financial professional before making any investment decisions.
XDB Accumulation - with XDB/BTC pairing.Accumulating XDB and running it in XDB/BTC pairing bots.. It is my coin for the year that may turn around and is finding it's bottom, if it hasnt already done so.
Current info
- XDB is an active project with updates informed vua Twitter and Medium
- It is a payment system that offers 10-15% in rewards after its used for a purchase at this time.
- They just launched payments in ASRoma, Doppleganger and Nuvolari (50 or so) stores. according the their Twitter handle Digitalbitsorg.
- In ... I believe MEXC AMA, they teased a large 900+ location brand chain that they are working with to launch Digibits for payments and rewards.
- Uses AtraX wallet
- It was primarily traded on Kucoin and Gate.io, but in the past month or two it has been listed on MEXC, CoinDCX, BTCEX, Deepcoin, etc.
- Also according to their Twitter, "#Defi is coming. AMM and liquidity pools are part of the V18 update, which is in testnet."
- Tokenomics roughly 3b/20b circulting. Some have been burned, some donated to Ukraine (address untouched since donation as of now).
- A token release/minting schedule is unknown.
I've been accumulating for a month or two.It has an ATH of 0.84 and is currently trading at ~0.00138. I'll be accumulating 0.0002-0.006. It's All time low is 0.00113147 on Kucoin. Which is down 99.xx%. Given the project being active, payments/rewrds available in a growing list of new stores, and DEFI in testnet the project appears to be undervalued. Weekly volume since October 2022-current is roughly 50x when copared to 2021 when it had it's high of 0.84 which is good news, but the Tokenomics needs to be monitored.
$REE - 3 month bottom base formed, ready for a boom!REE Automotive has formed a base ~4$ for the past 3 months. It has announced partnerships with Magna International, American Axle, Hino, Hitachi, J.B. Poindexter, Mitsubishi, Navya, Maxion, and more. Rumors around a UPS partnership as well. January 5-8 is CES in which they will be displaying their autonomous vehicle named Leopard and their FlatFormer base. It was originally a SPAC valued at 10$ NAV that hit around 16$. The technology and partnerships are becoming hard to ignore. This is not financial advice and is my own opinion. I have a holding in REE.